Compare CRDO & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDO | HSIC |
|---|---|---|
| Founded | 2008 | 1932 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.7B | 9.8B |
| IPO Year | 2022 | 1996 |
| Metric | CRDO | HSIC |
|---|---|---|
| Price | $152.01 | $88.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 16 |
| Target Price | ★ $179.62 | $85.07 |
| AVG Volume (30 Days) | ★ 6.6M | 789.9K |
| Earning Date | 06-01-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 765.52 | 7.21 |
| EPS | 0.67 | ★ 1.74 |
| Revenue | $1,335,116,000.00 | ★ $13,201,995,000.00 |
| Revenue This Year | $210.92 | $6.12 |
| Revenue Next Year | $57.22 | $3.64 |
| P/E Ratio | $241.93 | ★ $50.78 |
| Revenue Growth | ★ 205.68 | 5.94 |
| 52 Week Low | $86.49 | $61.97 |
| 52 Week High | $308.67 | $92.18 |
| Indicator | CRDO | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 29.74 | 49.27 |
| Support Level | $148.94 | $87.67 |
| Resistance Level | $160.45 | $89.32 |
| Average True Range (ATR) | 10.71 | 1.51 |
| MACD | -6.31 | -0.36 |
| Stochastic Oscillator | 0.00 | 29.15 |
Credo Technology Group Holding Ltd provides connectivity solutions for AI-driven applications, cloud computing, and hyperscale networks. Its high-speed copper and optical interconnect products support data infrastructure demands. The Company's product portfolio includes ZeroFlap (ZF) Active Electrical Cables (AECs), ZF optical transceivers, OmniConnect memory solutions, and retimers and DSPs for optical and copper Ethernet and PCIe, leveraging the PILOT diagnostic and analytics software platform. Its products are based on Serializer/Deserializer (SerDes) and Digital Signal Processor (DSP) technologies and include integrated circuits (ICs), Active Electrical Cables (AECs), SerDes Chiplets, and SerDes IP licensing solutions. The United States generates the maximum revenue.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.